HEAD AND NECK NEOPLASMS
Clinical trials for HEAD AND NECK NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK NEOPLASMS trials appear
Sign up with your email to follow new studies for HEAD AND NECK NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted lung cancer drug tested against chemo in phase 3 trial
Disease control TerminatedThis study tested a new targeted pill, pralsetinib, against standard chemotherapy for people with a specific type of advanced lung cancer (RET fusion-positive) who had not yet received treatment. The goal was to see if the targeted drug could delay cancer growth better than chemo…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 17, 2026 08:03 UTC
-
New drug combo aims to boost head and neck cancer treatment
Disease control TerminatedThis study tested a new drug called xevinapant combined with chemotherapy and radiation for people with head and neck cancer who cannot take the standard drug cisplatin. The goal was to find the safest dose and see how well the combination works. The study was stopped early, but …
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 08, 2026 12:00 UTC
-
PET scans reveal where cancer drug goes in patients
Knowledge-focused TerminatedThis early-phase study used special PET scans to track an experimental drug (BI 754111) in patients with advanced lung or head/neck cancer. The goal was to see where the drug goes in the body and how much reaches tumors. Only 8 patients were enrolled before the study was stopped …
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated May 17, 2026 07:59 UTC